Revenue
2020
2021
2022
2023
2024
2025
Zomedica Corp. (ZOMDF)
Price$0.0839Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.0M | $27.3M | $25.2M | $18.9M | $4.1M | $0 | — | — | — | — |
| Gross profit | $21.7M | $19.1M | $17.3M | $13.5M | $3.1M | $0 | — | — | — | — |
| Gross margin | 67.68% | 69.95% | 68.76% | 71.15% | 73.89% | — | — | — | — | — |
| Research & development | $7.2M | $7.3M | $5.7M | $2.6M | $1.7M | $8.0M | $10.3M | $10.3M | $2.8M | $1.5M |
| Operating expenses | $106.0M | $70.1M | $60.6M | $35.4M | $24.4M | $16.8M | — | — | — | — |
| Operating income | −$84.4M | −$51.1M | −$43.3M | −$21.9M | −$21.4M | −$16.8M | −$19.8M | −$16.6M | −$8.1M | −$5.7M |
| Operating margin | −263.36% | −187.11% | −171.82% | −115.81% | −517.15% | — | — | — | — | — |
| EBITDA | −$76.4M | −$43.1M | −$37.0M | −$17.9M | −$20.2M | −$16.5M | −$19.5M | −$16.4M | −$8.0M | −$5.7M |
| EBITDA margin | −238.53% | −157.84% | −146.82% | −94.46% | −489.60% | — | — | — | — | — |
| Net income | −$81.9M | −$47.0M | −$34.5M | −$17.0M | −$18.4M | −$16.9M | −$19.8M | −$16.6M | −$8.1M | −$5.7M |
| Net profit margin | −255.57% | −172.19% | −137.10% | −89.88% | −444.81% | — | — | — | — | — |
| Basic EPSper basic share | -$0.08 | -$0.05 | -$0.04 | -$0.02 | -$0.05 | -$0.05 | -$0.19 | -$0.18 | -$0.09 | -$0.07 |
| Diluted EPSper diluted share | -$0.08 | -$0.05 | -$0.04 | -$0.02 | -$0.05 | -$0.05 | -$0.19 | -$0.18 | -$0.09 | -$0.07 |
Owners
Reported shareholders
≈0.62%of listed shares
Klass Russell Kevin6.11M shares · May 21, 2026
View holders
| Holder | % owned |
|---|---|
Klass Russell Kevin | ≈0.62%6.11M shares |
POWERS JOHNNY D | ≈0.45%4.43M shares |
HEATON LARRY C II | ≈0.13%1.25M shares |
Blair Anthony K | ≈0.10%1M shares |
Williams Rodney James | ≈0.03%301.9K shares |
Jordan Scott | ≈0.03%300K shares |
MACLEOD CHRISTOPHER ROSS | ≈0.01%143K shares |
DeHaan-Fullerton Karen | ≈0.01%104.3K shares |
Ancora Advisors LLC | <0.01%83.61K shares |
CoreCap Advisors, LLC | <0.01%4.8K shares |
GILL CAPITAL PARTNERS, LLC | <0.01%2.72K shares |
HARBOUR INVESTMENTS, INC. | <0.01%2.2K shares |
EverSource Wealth Advisors, LLC | <0.01%1K shares |
Bogart Wealth, LLC | <0.01%680 shares |
Farther Finance Advisors, LLC | <0.01%86 shares |
Rowe Jeffrey M | —— shares |
Percentages use 979.95M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 21, 2026Form 4 | Klass Russell KevinSr. Vice President, Sales | BuyCommon Stock, without par value · indirect | 104.0K | $0.10 | $10.4K | 104.0K |
| May 21, 2026Form 4 | Klass Russell KevinOther | BuyCommon Stock, without par value | 5.5K | $0.11 | $605.00 | 6.00M |
| May 21, 2026Form 4 | Klass Russell KevinOther | BuyCommon Stock, without par value | 11.4K | $0.11 | $1.3K | 6.00M |
| May 20, 2026Form 4 | POWERS JOHNNY DDirector | BuyCommon Stock, without par value | 97.5K | $0.10 | $9.8K | 4.42M |
| May 20, 2026Form 4 | Klass Russell KevinOther | BuyCommon Stock, without par value | 200.0K | $0.11 | $22.0K | 5.98M |